Insider filing · BBIO

Brian C Stephenson sold $2.5M of BridgeBio Pharma (BBIO)

Executed Jan 28 2025, disclosed Jan 30 2025, 2 days later.

Returns are measured on stock purchases only.

BS Brian C Stephenson Secretary, Treasurer & CFO profile →

Brian C Stephenson (Secretary, Treasurer & CFO) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales), most often in BridgeBio Pharma, Inc. (BBIO). Across 3 priced purchase filings, the average 21-session return was +19.4% from execution and +15.7% from disclosure (delay-adjusted; derived). The largest single filing was $209K of FTH (8,655 sh across 2 lots, as filed), executed Jun 30.

BBIO BridgeBio Pharma, Inc. BBIO · Healthcare · 72 filings in 24 months ticker →

Healthcare · BridgeBio Pharma, Inc., a biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→